UTC Investment Co. logo

UTC Investment Co.

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

UTC Investment Co. is a private equity and venture capital firm specializing in buyouts and investments in start-ups.

Investor Profile

UTC Investment Co. has backed more than 15 startups, with 6 new investments in the last 12 months alone. The firm has led 3 rounds, about 20% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in South Korea, France, United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 3 rounds in the past year.

Stage Focus

  • Series B (47%)
  • Series A (20%)
  • Series C (13%)
  • Series Unknown (13%)
  • Seed (7%)

Country Focus

  • South Korea (80%)
  • France (13%)
  • United States (7%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Food And Beverage
  • Medical Device
  • Software
  • Pharmaceutical
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UTC Investment Co. frequently co-invest with?

JB Ventures
Asia, Kyonggi-do, South Korea, Dongan
Co-Investments: 1
DI
North America, Texas, United States, Houston
Co-Investments: 1
Stonebridge Capital
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Sambrinvest
Europe, Hainaut, Belgium, Gosselies
Co-Investments: 2
Sejong Venture Partners
North America, New Jersey, United States, Fort Lee
Co-Investments: 1
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 3
Strong Ventures
North America, California, United States, Los Angeles
Co-Investments: 2
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 2
Otium Capital
Europe, Corse, France, Saint Joseph
Co-Investments: 2
LSK Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by UTC Investment Co.?

AD System

Hannam, Kangwon-do, South Korea

AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.

Drone ManagementDronesManufacturing
SeedJun 19, 2025
Amount Raised: $725,337
Pebble Square

Seongnam, Kyonggi-do, South Korea

Pebble Square designs new processing-in-memory architecture that improves AI performance and power efficiency.

Artificial Intelligence (AI)Information TechnologySoftware
Series UnknownMar 10, 2025
Amount Raised: $1,377,049
WASHSWAT

Seoul, Seoul-t'ukpyolsi, South Korea

Washswat is a laundry service that washes and dries the laundry that is operated by specialized facilities and personnel.

Home ServicesLaundry and Dry-cleaningMobile Apps
Series CNov 27, 2024
Amount Raised: $5,026,954
Solmedix

Mapo, Seoul-t'ukpyolsi, South Korea

Development user-oriented new concept medical devices through the MOSAIC Platform.

Health CareMedicalMedical Device
Series UnknownNov 13, 2024
Amount Raised: $1,068,194
Lucas

Yeoksamdong, Seoul-t'ukpyolsi, South Korea

Lucas develops a system to detect, measure, categorize and track nodules in the screening CT images.

Medical DeviceSoftware
Series BOct 2, 2024
Amount Raised: $5,282,560
Allround Doctors

Seoul, Seoul-t'ukpyolsi, South Korea

Allround Doctors is a digital healthcare startup that develops digital medical devices for cancer patients.

Health CareMedical
Series AAug 6, 2024
Amount Raised: $5,099,123
Rznomics

Gwangju, Kwangju-jikhalsi, South Korea

Rznomics is a biotechnology company.

BiopharmaBiotechnology
Series CJun 8, 2022
Amount Raised: $29,587,713
Autotelic Bio

Cheongju, Ch'ungch'ong-bukto, South Korea

Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs.

BiotechnologyPharmaceuticalProduct Research
Series BMar 28, 2022
Amount Raised: $12,665,468
Creatz

Suwon, Ch'ungch'ong-namdo, South Korea

Creatz is a sports consulting online platform based on artificially generated data.

Artificial Intelligence (AI)Online PortalsSports
Series ADec 8, 2021
Amount Raised: $21,319,234
PDC*line Pharma

La Tronche, Rhone-Alpes, France

PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells.

BiotechnologyHealth CareTherapeutics
Series BDec 6, 2021
Amount Raised: $13,314,903